PMC Links for Books (Select 2826166) - PMC

Select item 50365381.

Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Chiara Elena, Anna Gallì, Esperanza Such, Manja Meggendorfer, Ulrich Germing, Ettore Rizzo, Jose Cervera, Elisabetta Molteni, Annette Fasan, Esther Schuler, Ilaria Ambaglio, Maria Lopez-Pavia, Silvia Zibellini, Andrea Kuendgen, Erica Travaglino, Reyes Sancho-Tello, Silvia Catricalà, Ana I. Vicente, Torsten Haferlach, Claudia Haferlach, Guillermo F. Sanz, Luca Malcovati, Mario Cazzola

Blood. 2016 Sep 8; 128(10): 1408–1417. Prepublished online 2016 Jul 6. doi: 10.1182/blood-2016-05-714030

PMCID:: PMC5036538

Abstract Article

Select item 49157922.

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Michael R. Savona, Luca Malcovati, Rami Komrokji, Ramon V. Tiu, Tariq I. Mughal, Attilio Orazi, Jean-Jacques Kiladjian, Eric Padron, Eric Solary, Raoul Tibes, Raphael Itzykson, Mario Cazzola, Ruben Mesa, Jaroslaw Maciejewski, Pierre Fenaux, Guillermo Garcia-Manero, Aaron Gerds, Guillermo Sanz, Charlotte M. Niemeyer, Francisco Cervantes, Ulrich Germing, Nicholas C. P. Cross, Alan F. List

Blood. 2015 Mar 19; 125(12): 1857–1865. Prepublished online 2015 Jan 26. doi: 10.1182/blood-2014-10-607341

PMCID:: PMC4915792

Abstract Article

Select item 43472593.

GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia

Eric Padron, Jeffrey S. Painter, Sateesh Kunigal, Adam W. Mailloux, Kathy McGraw, Jessica M. McDaniel, Eunhee Kim, Christopher Bebbington, Mark Baer, Geoffrey Yarranton, Jeffrey Lancet, Rami S. Komrokji, Omar Abdel-Wahab, Alan F. List, Pearlie K. Epling-Burnette

Blood. 2013 Jun 20; 121(25): 5068–5077. Prepublished online 2013 Apr 30. doi: 10.1182/blood-2012-10-460170

PMCID:: PMC4347259

Abstract Article

Select item 41487734.

Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia

Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, Chiara Elena, Anna Gallì, Matteo G. Della Porta, Erica Travaglino, Daniela Pietra, Cristiana Pascutto, Marta Ubezio, Elisa Bono, Matteo C. Da Vià, Angela Brisci, Francesca Bruno, Laura Cremonesi, Maurizio Ferrari, Emanuela Boveri, Rosangela Invernizzi, Peter J. Campbell, Mario Cazzola

Blood. 2014 Aug 28; 124(9): 1513–1521. Prepublished online 2014 Jun 26. doi: 10.1182/blood-2014-03-560227

PMCID:: PMC4148773

Abstract Article

Select item 40868085.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List, Steven D Gore, John F Seymour, John M Bennett, John Byrd, Jay Backstrom, Linda Zimmerman, David McKenzie, C L Beach, Lewis R Silverman, for the International Vidaza High-Risk MDS Survival Study Group

Lancet Oncol. Author manuscript; available in PMC 2014 Jul 8.

Published in final edited form as: Lancet Oncol. 2009 Mar; 10(3): 223–232. Published online 2009 Feb 21. doi: 10.1016/S1470-2045(09)70003-8

PMCID:: PMC4086808

Abstract Article PDF–920K

Select item 35800406.

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

Manja Meggendorfer, Andreas Roller, Torsten Haferlach, Christiane Eder, Frank Dicker, Vera Grossmann, Alexander Kohlmann, Tamara Alpermann, Kenichi Yoshida, Seishi Ogawa, H. Phillip Koeffler, Wolfgang Kern, Claudia Haferlach, Susanne Schnittger

Blood. 2012 Oct 11; 120(15): 3080–3088. Prepublished online 2012 Aug 23. doi: 10.1182/blood-2012-01-404863

PMCID:: PMC3580040

Abstract Article

Select item 35250207.

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

Mikkael A. Sekeres, Ramon V. Tiu, Rami Komrokji, Jeffrey Lancet, Anjali S. Advani, Manuel Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, Jennifer Paleveda, Ali Tabarroki, Valeria Visconte, Hideki Makishima, Andres Jerez, Ronald Paquette, Alan F. List, Jaroslaw P. Maciejewski

Blood. 2012 Dec 13; 120(25): 4945–4951. Prepublished online 2012 Aug 22. doi: 10.1182/blood-2012-06-434639

PMCID:: PMC3525020

Abstract Article

Select item 27919428.

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Olivier Kosmider, Véronique Gelsi-Boyer, Marion Ciudad, Cindy Racoeur, Valérie Jooste, Norbert Vey, Bruno Quesnel, Pierre Fenaux, Jean-Noël Bastie, Odile Beyne-Rauzy, Aspasia Stamatoulas, François Dreyfus, Norbert Ifrah, Stéphane de Botton, William Vainchenker, Oliver A. Bernard, Daniel Birnbaum, Michaëla Fontenay, Eric Solary

Haematologica. 2009 Dec; 94(12): 1676–1681. Published online 2009 Oct 1. doi: 10.3324/haematol.2009.011205

PMCID:: PMC2791942

Abstract Article PDF–179K

Select item 20335379.

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.

C. A. Stiller, J. M. Chessells, M. Fitchett

Br J Cancer. 1994 Nov; 70(5): 969–972. doi: 10.1038/bjc.1994.431

PMCID:: PMC2033537

Summary Page Browse PDF–782K

Select item 189555610.

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

Hadrian Szpurka, Ramon Tiu, Gurunathan Murugesan, Samer Aboudola, Eric D. Hsi, Karl S. Theil, Mikkael A. Sekeres, Jaroslaw P. Maciejewski

Blood. 2006 Oct 1; 108(7): 2173–2181. Prepublished online 2006 Jun 1. doi: 10.1182/blood-2006-02-005751

PMCID:: PMC1895556

Abstract Article

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 10

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity